These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16774755)

  • 61. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study.
    Yarnell J; Yu S; McCrum E; Arveiler D; Hass B; Dallongeville J; Montaye M; Amouyel P; Ferrières J; Ruidavets JB; Evans A; Bingham A; Ducimetière P;
    Int J Epidemiol; 2005 Apr; 34(2):268-75. PubMed ID: 15319403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.
    Troughton JA; Woodside JV; Yarnell JW; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Luc G;
    Atherosclerosis; 2008 Apr; 197(2):556-63. PubMed ID: 17900591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):79-84. PubMed ID: 17301631
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study.
    Bataille V; Perret B; Troughton J; Amouyel P; Arveiler D; Woodside J; Dallongeville J; Haas B; Bingham A; Ducimetière P; Ferrières J
    Int J Cardiol; 2006 Apr; 108(2):189-96. PubMed ID: 15925416
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Respective contribution of conventional risk factors and antihypertensive treatment to stable angina pectoris and acute coronary syndrome as the first presentation of coronary heart disease: the PRIME Study.
    Canoui-Poitrine F; Luc G; Juhan-Vague I; Morange PE; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Ducimetiere P; Empana JP;
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):550-5. PubMed ID: 19629011
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Homocysteine and coronary heart disease risk in the PRIME study.
    Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
    Atherosclerosis; 2007 Mar; 191(1):90-7. PubMed ID: 16774755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.
    Humphrey LL; Fu R; Rogers K; Freeman M; Helfand M
    Mayo Clin Proc; 2008 Nov; 83(11):1203-12. PubMed ID: 18990318
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.